Patents by Inventor Ulrike Utans-Schneitz

Ulrike Utans-Schneitz has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Chemokine
    Publication number: 20030175895
    Abstract: The present invention relates to the discovery of novel genes and proteins, which function in pathways involved in brain pathogenesis. In particular, the novel genes and proteins relate to inflammatory tissue responses caused by brain injuries such trauma, ischemia or autoimmune-inflammation or other diseases or processes related to neuroinflammation. The compounds disclosed in the present invention are useful as therapeutics, diagnostics and in screening assays.
    Type: Application
    Filed: January 16, 2003
    Publication date: September 18, 2003
    Inventors: Werner Lesslauer, Ulrike Utans-Schneitz
  • Chemokine
    Patent number: 6537794
    Abstract: The present invention relates to the discovery of novel genes and proteins, which function in pathways involved in brain pathogenesis. In particular, the novel genes and proteins relate to inflammatory tissue responses caused by brain injuries such trauma, ischemia or autoimmune-inflammation or other diseases or processes related to neuroinflammation. The compounds disclosed in the present invention are useful as therapeutics, diagnostics and in screening assays.
    Type: Grant
    Filed: October 25, 1999
    Date of Patent: March 25, 2003
    Assignee: Hoffmann-La Roche Inc.
    Inventors: Werner Lesslauer, Ulrike Utans-Schneitz
  • Chemokine
    Patent number: 6057426
    Abstract: The present invention relates to the discovery of novel genes and proteins, which function in pathways involved in brain pathogenesis. In particular, the novel genes and proteins relate to inflammatory tissue responses caused by brain injuries such trauma, ischemia or autoimmune-inflammation or other diseases or processes related to neuroinflammation. The compounds disclosed in the present invention are useful as therapeutics, diagnostics and in screening assays.
    Type: Grant
    Filed: April 30, 1998
    Date of Patent: May 2, 2000
    Assignee: Hoffmann-La Roche Inc.
    Inventors: Werner Lesslauer, Ulrike Utans-Schneitz